Windlas Biotech Limited — Others, 30-12-2024: Trading Window

Windlas Biotech Limited has announced a board meeting to discuss the financial results for the quarter and nine months ended December 31, 2024. In the interim, the Trading Window for the Company’s securities will be closed from January 1, 2025, until 48 hours after the financial results are publicly released. This closure is a standard practice to ensure compliance with trading policies. Investors should note this window may affect trading activity, introducing a potential risk if market reactions are volatile following the results release, but it also demonstrates the company’s discipline in maintaining regulatory standards.